articleTop 1% cited

A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization

American Journal of Transplantation · 2009 · Vol. 9(8) · pp. 1920–1928

Robert J. Lewandowski(Northwestern Memorial Hospital)Laura Kulik(Northwestern University)Ahsun Riaz(Robert H. Lurie Comprehensive Cancer Center of Northwestern University)Sean Senthilnathan(Robert H. Lurie Comprehensive Cancer Center of Northwestern University)Mary F. Mulcahy(Northwestern University)Robert K. Ryu(Northwestern Memorial Hospital)S.M. Ibrahim(Robert H. Lurie Comprehensive Cancer Center of Northwestern University)K.T. Sato(Robert H. Lurie Comprehensive Cancer Center of Northwestern University)Talia Baker(Northwestern University)Frank H. Miller(Robert H. Lurie Comprehensive Cancer Center of Northwestern University)Reed A. Omary(Northwestern Memorial Hospital)Michaël Abécassis(Northwestern University)Riad Salem✉(Northwestern University)

View via DOI Publisher page

Hepatocellular Carcinoma Treatment and Prognosis Liver Disease and Transplantation Liver Disease Diagnosis and TreatmentMedicineHepatocellular carcinomaMicrosphereInternal medicineOverall survivalResponse Evaluation Criteria in Solid TumorsProgressive diseaseComplete responseNuclear medicineGastroenterology

MeSH terms

AdultAgedAged, 80 and overEmbolization, TherapeuticFemaleFollow-Up StudiesCarcinoma, HepatocellularHumansLiver NeoplasmsMaleMiddle AgedNeoplasm StagingRetrospective StudiesYttrium RadioisotopesLiver Transplantation

Citations

572

FWCI

15.89

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

References

Sorafenib in Advanced Hepatocellular Carcinoma